全球糖尿病監測設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計糖尿病監測設備市場將從 2025 年的 112.3 億美元成長到 2034 年的 241.6 億美元，2026 年至 2034 年的複合年成長率為 8.89%。

由於全球糖尿病盛行率不斷上升，全球糖尿病監測設備市場正經歷強勁成長。久坐不動的生活方式、不健康的飲食習慣以及日益嚴重的肥胖問題等因素，都導致了糖尿病患者人數的增加。糖尿病監測設備能夠幫助患者定期監測血糖值，從而更好地管理病情，並降低血糖值控制不佳引發併發症的風險。

技術創新正在顯著改變糖尿病監測解決方案。持續血糖監測（CGM）系統、穿戴式感測器和智慧血糖儀因其能夠提供即時數據和更高的準確性而日益普及。許多最新設備還能與行動應用程式整合，使患者和醫護人員能夠更有效地監測血糖值趨勢並調整治療方案。

隨著醫療保健系統日益重視預防醫學和數位化醫療，糖尿病監測設備市場前景廣闊。穿戴式健康技術和遠端患者監護的廣泛應用預計將推動市場成長。發展中地區醫療保健服務的改善以及非侵入性血糖監測技術的持續創新將進一步提升市場機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球糖尿病監測設備市場：依產品類型分類

• 市場分析、洞察與預測
• 自測血糖儀
• 連續血糖監測設備

第5章：全球糖尿病監測設備市場：依適應症分類

• 市場分析、洞察與預測
• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病

第6章 全球糖尿病監測設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 門診手術中心
• 居家醫療環境
• 其他

第7章 全球糖尿病監測設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • I-SENS Inc
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services Inc
  • Medtronic Plc
  • Dexcom Inc
  • Abbott Laboratories
  • Labiotech UG
  • ARKRAY Inc
  • Cnoga Medical Ltd
  • Sanofi SA
  • LifeScan Inc

The Diabetes Monitoring Devices Market size is expected to reach USD 24.16 Billion in 2034 from USD 11.23 Billion (2025) growing at a CAGR of 8.89% during 2026-2034.

The global diabetes monitoring devices market is experiencing strong growth due to the rising global prevalence of diabetes. Factors such as sedentary lifestyles, unhealthy diets, and increasing obesity rates are contributing to a growing diabetic population. Diabetes monitoring devices help patients track blood glucose levels regularly, enabling better disease management and reducing the risk of complications associated with uncontrolled blood sugar levels.

Technological advancements are significantly transforming diabetes monitoring solutions. Continuous glucose monitoring (CGM) systems, wearable sensors, and smart glucose meters are gaining popularity because they provide real-time data and improved accuracy. Many modern devices also integrate with mobile applications, allowing patients and healthcare providers to monitor glucose trends and adjust treatment plans more effectively.

The future of the diabetes monitoring devices market appears promising as healthcare systems emphasize preventive care and digital health integration. Increasing adoption of wearable health technologies and remote patient monitoring is expected to support market growth. Expanding healthcare access in developing regions and ongoing innovations in non-invasive glucose monitoring technologies will further strengthen market opportunities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Self-Monitoring Blood Glucose Devices
• Continuous Glucose Monitoring Devices

By Indication

• Type-I Diabetes
• Type-II Diabetes
• Gestational Diabetes

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Center
• Home Care Settings
• other

COMPANIES PROFILED

• iSENS Inc, Ascensia Diabetes Care Holdings AG, Bayer AG, F HoffmannLa Roche Ltd, Johnson Johnson Services Inc, Medtronic plc, Dexcom Inc, Abbott Laboratories, Labiotech UG, ARKRAY Inc, Cnoga Medical Ltd, Sanofi SA, LifeScan Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIABETES MONITORING DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Self-Monitoring Blood Glucose Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Continuous Glucose Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIABETES MONITORING DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Type-I Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type-II Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gestational Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIABETES MONITORING DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIABETES MONITORING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIABETES MONITORING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 I-SENS Inc
  • 9.2.2 Ascensia Diabetes Care Holdings AG
  • 9.2.3 Bayer AG
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Johnson & Johnson Services Inc
  • 9.2.6 Medtronic Plc
  • 9.2.7 Dexcom Inc
  • 9.2.8 Abbott Laboratories
  • 9.2.9 Labiotech UG
  • 9.2.10 ARKRAY Inc
  • 9.2.11 Cnoga Medical Ltd
  • 9.2.12 Sanofi S.A
  • 9.2.13 LifeScan Inc